title: Targeted treatment for amyloidosis.
authors: Miriam E
authors: ME
authors: Pepys-Vered
authors: Mark B
authors: MB
authors: Pepys
mesh_terms: D000682:Amyloid / Q000145:classification / Q000378:metabolism; D000686:Amyloidosis / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D002264:Carboxylic Acids / Q000494:pharmacology*; D019468:Disease Management; D015316:Genetic Therapy; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods; D058225:Plaque, Amyloid / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D011228:Prealbumin / Q000378:metabolism*; D055550:Protein Stability / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology*; D064449:Sequestering Agents / Q000494:pharmacology; D000685:Serum Amyloid A Protein / Q000378:metabolism*; D000683:Serum Amyloid P-Component / Q000378:metabolism
chemical_list: D000682:Amyloid; D002264:Carboxylic Acids; D011228:Prealbumin; D011759:Pyrrolidines; C455899:R-1-(6-(R-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid; D064449:Sequestering Agents; D000685:Serum Amyloid A Protein; D000683:Serum Amyloid P-Component